| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/2001 | CA2119363C 10-desacetoxytaxol derivatives |
| 07/17/2001 | CA2065040C Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 07/17/2001 | CA2034197C Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/17/2001 | CA2034025C Fluid ophthalmic composition based on lipid microparticles containing at least one active principle |
| 07/12/2001 | WO2001049885A1 EGS MOLECULES THAT SPECIFICALLY DOWNREGULATE bcl-xL EXPRESSION |
| 07/12/2001 | WO2001049869A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049822A2 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 07/12/2001 | WO2001049775A2 Antisense antibacterial cell division composition and method |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049704A1 Compound (i), a method for extracting it and a pharmaceutical composition containing it |
| 07/12/2001 | WO2001049703A2 Substituted sapogenins and their use |
| 07/12/2001 | WO2001049700A1 Imidazopyrimidine nucleoside analogues with anti-hiv activity |
| 07/12/2001 | WO2001049699A1 Macrolide antiinfective agents |
| 07/12/2001 | WO2001049698A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | WO2001049696A1 N,o-amidomalonate platinum complexes |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 07/12/2001 | WO2001049688A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | WO2001049687A2 Cyclohexene nucleic acids |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049683A1 Novel heteroaryl derivatives, their preparation and use |
| 07/12/2001 | WO2001049682A1 Condensed azepines as vasopressin agonists |
| 07/12/2001 | WO2001049680A1 Novel indole derivatives |
| 07/12/2001 | WO2001049679A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 07/12/2001 | WO2001049678A1 Substituted phenyl-piperazine derivatives, their preparation and use |
| 07/12/2001 | WO2001049677A1 Phenylpiperazinyl derivatives |
| 07/12/2001 | WO2001049676A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 07/12/2001 | WO2001049675A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 07/12/2001 | WO2001049674A2 Glycosidase inhibitors and preparation thereof |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049670A1 5,10-dihydroacridines as calcium channel blockers |
| 07/12/2001 | WO2001049667A1 Method for preparing hydroxypicolinic acid derivatives |
| 07/12/2001 | WO2001049666A1 Picolinic acid derivatives and their use as fungicides |
| 07/12/2001 | WO2001049663A2 Non-peptide inhibition of t-lymphocyte activation and therapies related thereto |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/12/2001 | WO2001049657A1 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 07/12/2001 | WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | WO2001049650A1 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl |
| 07/12/2001 | WO2001049324A2 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | WO2001049323A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049322A1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension |
| 07/12/2001 | WO2001049317A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/12/2001 | WO2001049316A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 07/12/2001 | WO2001049315A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049307A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/12/2001 | WO2001049300A2 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium |
| 07/12/2001 | WO2001049298A2 Novel therapeutic use of enoxaparin |
| 07/12/2001 | WO2001049297A1 Methods for inhibiting/treating hiv infections and aids related symptoms |
| 07/12/2001 | WO2001049296A1 Antimicrobial compositions and methods of use |
| 07/12/2001 | WO2001049295A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | WO2001049294A1 Product for treating gynecomastia |
| 07/12/2001 | WO2001049293A1 A lower toxicity and anti-inflammatory and anti-exudation pharmaceutical composition |
| 07/12/2001 | WO2001049292A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | WO2001049291A1 10,11-difluoromethylenedioxycamptothecin compounds with topoisomerase i inhibition |
| 07/12/2001 | WO2001049290A1 Methods and reagents for facilitating transcription |
| 07/12/2001 | WO2001049289A1 Pharmaceutical and veterinary uses of endothelin antagonists |
| 07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | WO2001049287A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 07/12/2001 | WO2001049286A1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 07/12/2001 | WO2001049285A1 Flavonoid drug and dosage form, its production and use |
| 07/12/2001 | WO2001049284A1 Composition for stabilizing and potentiating the action of anti-angiogenic substances by polyunsaturated fatty acids |
| 07/12/2001 | WO2001049283A1 Preparations for the non-traumatic excision of a nail |
| 07/12/2001 | WO2001049282A2 Therapeutic preparations of highly unsaturated fatty acids |
| 07/12/2001 | WO2001049281A2 POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES |
| 07/12/2001 | WO2001049280A2 Weight promoting composition, method, and product |
| 07/12/2001 | WO2001049279A2 Use of steroidal alkaloids to reverse multidrug resistance |
| 07/12/2001 | WO2001049278A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 07/12/2001 | WO2001049277A2 Immune response modulation |
| 07/12/2001 | WO2001049276A2 Anhydrous gel comprising nsaid for topical administration to the oral cavity |
| 07/12/2001 | WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters |
| 07/12/2001 | WO2001049269A1 Sustained-releasing anthelmintic compositions comprising praziquantel |
| 07/12/2001 | WO2001049268A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| 07/12/2001 | WO2001049267A1 Multi-tablet oxybutynin system for treating incontinence |
| 07/12/2001 | WO2001049264A2 Pharmaceutical compositions for oral administration |
| 07/12/2001 | WO2001049263A1 Inhalation particles |
| 07/12/2001 | WO2001049261A2 Stable aqueous deoxyfructosazine solution |
| 07/12/2001 | WO2001049250A2 Treatment of acne using lipoic acid |
| 07/12/2001 | WO2001049242A2 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside |
| 07/12/2001 | WO2001049133A1 Application of vicinal dithioglycol as food additive |
| 07/12/2001 | WO2001044485A8 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 07/12/2001 | WO2001044207A8 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 07/12/2001 | WO2001021604A8 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp) |
| 07/12/2001 | WO2001012166A3 Improved treatment for acute physical insult to the central nervous system |
| 07/12/2001 | WO2001008677A8 Methods of inhibiting osteoclast activity |
| 07/12/2001 | WO2001007087A8 Enzyme catalyzed anti-infective therapeutic agents |
| 07/12/2001 | WO2001005363B1 Sunscreen for the scalp and hair |
| 07/12/2001 | WO2001004113A3 Process for the preparation of paroxetine and synthetic intermeditates thereof |
| 07/12/2001 | WO2001003669A3 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 07/12/2001 | WO2001002391A3 Bicyclic aromatic compounds for treating drug addiction |
| 07/12/2001 | WO2001002358A3 Cyclized amide derivatives for treating or preventing neuronal damage |
| 07/12/2001 | WO2001001956A3 Solid preparations containing paroxetine |
| 07/12/2001 | WO2000078697A3 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 07/12/2001 | WO2000077034A3 Amino acids from fish and soy proteins improve insulin sensitivity |
| 07/12/2001 | WO2000076529A3 Use of estrogen receptor agonists or antagonists for treating growth, bone disorders |
| 07/12/2001 | WO2000076500A3 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |